These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12851994)

  • 21. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Irbesartan].
    Caballero E; Sádaba B; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1998; 42(3):166-9. PubMed ID: 10420939
    [No Abstract]   [Full Text] [Related]  

  • 23. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists.
    Brabant SM; Eyraud D; Bertrand M; Coriat P
    Anesth Analg; 1999 Oct; 89(4):887-8. PubMed ID: 10512259
    [No Abstract]   [Full Text] [Related]  

  • 24. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AT1-receptor antagonism in hypertension: what has been learned with irbesartan?
    Waeber B; Burnier M
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):23-33. PubMed ID: 15030294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from migraine without aura to typical aura without headache after irbesartan.
    Pinessi L; Ferrero M; Gentile S; Rainero I
    J Headache Pain; 2005 Apr; 6(2):100. PubMed ID: 16362652
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary: do angiotensin II receptor antagonists regress left ventricular hypertrophy?
    Lip GY
    J Hum Hypertens; 1996 Nov; 10(11):725-7. PubMed ID: 9004101
    [No Abstract]   [Full Text] [Related]  

  • 28. [Organ protection in hypertensive type 2 diabetic patients. Double chance with AT1 blockers].
    MMW Fortschr Med; 2000 Jan; 142(3):58-9. PubMed ID: 10726465
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.
    Andrade RJ; Lucena MI; Fernández MC; Vega JL; García-Cortés M; Casado M; Guerrero-Sanchez E; Pulido-Fernandez F
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):887-90. PubMed ID: 12172412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Microalbuminuria in patients with hypertension and cardiovascular comorbidity, REAL observational study of treatment with Irbesartan/HCTZ].
    Tschöpe C; Tschöpe R; Unger T
    MMW Fortschr Med; 2006 Jun; 148(25):48. PubMed ID: 16859162
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR; Chen CH; Ding PY; Chen YT; Ting CT; Huang JL; Chiang AH; Liu CP; Tseng CJ; Chao CT; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Irbesartan: a new possibility in the treatment of hypertension].
    Rapi J
    Orv Hetil; 2002 May; 143(21):1187-92. PubMed ID: 12073539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based European cohort study of persistence in newly diagnosed hypertensive patients.
    Hasford J; Mimran A; Simons WR
    J Hum Hypertens; 2002 Aug; 16(8):569-75. PubMed ID: 12149663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of age and gender on the pharmacokinetics of irbesartan.
    Vachharajani NN; Shyu WC; Smith RA; Greene DS
    Br J Clin Pharmacol; 1998 Dec; 46(6):611-3. PubMed ID: 9862252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute pancreatitis associated with irbesartan therapy.
    Famularo G; Minisola G; Nicotra GC; De Simone C
    Pancreas; 2005 Oct; 31(3):294-5. PubMed ID: 16163066
    [No Abstract]   [Full Text] [Related]  

  • 36. [The control rate of irbesartan/hydrochlorothiazide combination regimen in the treatment of Chinese patients with mild to moderate hypertension].
    Sun NL; Jing S; Chen J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):618-21. PubMed ID: 16080809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Irbesartan--antihypertensive treatment in patients with heart failure and diabetes mellitus].
    Zukowska-Szczechowska E; Gosek K; Grzeszczak W
    Przegl Lek; 2002; 59(3):160-4. PubMed ID: 12184030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM; Goldberg AI
    Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Walser M
    N Engl J Med; 2002 Feb; 346(9):705-7. PubMed ID: 11873778
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.